{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:44:51Z","timestamp":1792518291622,"version":"4.5.0"},"reference-count":11,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Thorax"],"accepted":{"date-parts":[[2026,9,30]]},"DOI":"10.1136\/thorax-2026-225829","type":"journal-article","created":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:20:32Z","timestamp":1792516832000},"page":"thorax-2026-225829","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Nintedanib: does one size fit all?"],"prefix":"10.1136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4128-5554","authenticated-orcid":false,"given":"James W P","family":"May","sequence":"first","affiliation":[{"name":"Margaret Turner Warwick Centre for Fibrosing Lung Disease, National Heart and Lung Institute, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4294-0052","authenticated-orcid":false,"given":"Richard J","family":"Hewitt","sequence":"additional","affiliation":[{"name":"Margaret Turner Warwick Centre for Fibrosing Lung Disease, National Heart and Lung Institute, Imperial College London, London, UK"},{"name":"Royal Brompton Hospital, Guy's and St Thomas' NHS Foundation Trust, London, UK"},{"name":"King\u2019s Centre for Lung Health, King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,10,20]]},"reference":[{"key":"2026102010202388000_thorax-2026-225829v1.1","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2024-002773","article-title":"Idiopathic pulmonary fibrosis in the UK: findings from the British Thoracic Society UK Idiopathic Pulmonary Fibrosis Registry","volume":"12","author":"Fahim","year":"2025","journal-title":"BMJ Open Respir Res"},{"key":"2026102010202388000_thorax-2026-225829v1.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402584"},{"key":"2026102010202388000_thorax-2026-225829v1.3","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1007\/s12325-023-02454-9","article-title":"A Narrative Review of Real-World Data on the Safety of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis","volume":"40","author":"Podolanczuk","year":"2023","journal-title":"Adv Ther"},{"key":"2026102010202388000_thorax-2026-225829v1.4","first-page":"00049","article-title":"Safety and tolerability of nintedanib for the treatment of idiopathic pulmonary fibrosis in routine UK clinical practice","volume":"PMCID","author":"Fletcher","year":"2018","journal-title":"ERJ Open Res"},{"key":"2026102010202388000_thorax-2026-225829v1.5","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e27531","article-title":"Mechanism and treatment of diarrhea associated with tyrosine kinase inhibitors","volume":"10","author":"Liu","year":"2024","journal-title":"Heliyon"},{"key":"2026102010202388000_thorax-2026-225829v1.6","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00591-2021","article-title":"Mortality and survival in idiopathic pulmonary fibrosis: a systematic review and meta-analysis","volume":"8","author":"Zheng","year":"2022","journal-title":"ERJ Open Res"},{"key":"2026102010202388000_thorax-2026-225829v1.7","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2018-000397","article-title":"Safety and survival data in patients with idiopathic pulmonary fibrosis treated with nintedanib: pooled data from six clinical trials","volume":"6","author":"Lancaster","year":"2019","journal-title":"BMJ Open Respir Res"},{"key":"2026102010202388000_thorax-2026-225829v1.8","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-48593-4","article-title":"Gastrointestinal adverse effects of nintedanib and the associated risk factors in patients with idiopathic pulmonary fibrosis","volume":"9","author":"Kato","year":"2019","journal-title":"Sci Rep"},{"key":"2026102010202388000_thorax-2026-225829v1.9","doi-asserted-by":"crossref","unstructured":"Bassi I , Carpano M , Giancotti G , et al . Body composition is associated with nintedanib-related diarrhoea: risk stratification in idiopathic pulmonary fibrosis. Thorax 2026.:thorax-2026-225408. doi:10.1136\/thorax-2026-225408","DOI":"10.1136\/thorax-2026-225408"},{"key":"2026102010202388000_thorax-2026-225829v1.10","doi-asserted-by":"crossref","first-page":"10805","DOI":"10.21037\/jtd-2025-938","article-title":"Significance of clinical parameters and biomarkers to predict nintedanib-induced diarrhea: an interview-based retrospective study","volume":"17","author":"Arai","year":"2025","journal-title":"J Thorac Dis"},{"key":"2026102010202388000_thorax-2026-225829v1.11","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-015-0276-5","article-title":"Safety, tolerability and appropriate use of nintedanib in idiopathic pulmonary fibrosis","volume":"16","author":"Corte","year":"2015","journal-title":"Respir Res"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thorax-2026-225829","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:20:34Z","timestamp":1792516834000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thorax-2026-225829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,20]]},"references-count":11,"alternative-id":["10.1136\/thorax-2026-225829"],"URL":"https:\/\/doi.org\/10.1136\/thorax-2026-225829","relation":{},"ISSN":["0040-6376","1468-3296"],"issn-type":[{"value":"0040-6376","type":"print"},{"value":"1468-3296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,20]]}}}